التفاصيل البيبلوغرافية
| العنوان: |
GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells. |
| المؤلفون: |
da Silva Lima, Natália, Cabaleiro, Alba, Novoa, Eva, Riobello, Cristina, Knerr, Patrick J., He, Yantao, Esquinas-Román, Eva M., González-García, Ismael, Prevot, Vincent, Schwaninger, Markus, Dieguez, Carlos, López, Miguel, Müller, Timo D., Varela-Rey, Marta, Douros, Jonathan D., Nogueiras, Ruben |
| المصدر: |
Cellular & Molecular Life Sciences; 11/28/2024, Vol. 81 Issue 1, p1-16, 16p |
| مصطلحات موضوعية: |
HEPATIC fibrosis, PALMITIC acid, LIVER cells, GLYCEMIC control, DIRECT action, INSULIN |
| مستخلص: |
The use of incretin agonists for managing metabolic dysfunction-associated steatohepatitis (MASH) is currently experiencing considerable interest. However, whether these compounds have a direct action on MASH is still under debate. This study aims to investigate whether GLP-1R/GIPR agonists act directly in hepatocytes and hepatic stellate cells (HSCs). For this, human hepatocyte and HSCs lines, as well as primary human hepatocytes and HSCs treated with Liraglutide, Acyl-GIP or the GLP-1/GIP dual agonist (MAR709) were used. We show that the concentrations of each compound, which were effective in insulin release, did not induce discernible alterations in either hepatocytes or HSCs. In hepatocytes displaying elevated fatty acid content after the treatment with oleic acid and palmitic acid, none of the three compounds reduced lipid concentration. Similarly, in HSCs activated with transforming growth factor-β (TGFb), Liraglutide, Acyl-GIP and MAR709 failed to ameliorate the elevated expression of fibrotic markers. The three compounds were also ineffective in phosphorylating CREB, which mediates insulinotropic actions, in both hepatocytes and HSCs. These findings indicate that incretin agonists have no direct actions in human hepatocytes or hepatic stellate cells, suggesting that their beneficial effects in patients with MASH are likely mediated indirectly, potentially through improvements in body weight, insulin resistance and glycemic control. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cellular & Molecular Life Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder